47.71
Overview
News
Price History
Option Chain
Financials
Why DD Down?
Discussions
Forecast
Stock Split
Dividend History
Dupont De Nemours Inc stock is traded at $47.71, with a volume of 7.14M.
It is down -0.50% in the last 24 hours and down -1.91% over the past month.
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the healthcare, water, construction, automotive, aerospace, and printing and packaging industries. Healthcare and water will generate the majority of profits.
See More
Previous Close:
$47.95
Open:
$48.6
24h Volume:
7.14M
Relative Volume:
1.97
Market Cap:
$19.33B
Revenue:
$9.70B
Net Income/Loss:
$588.00M
P/E Ratio:
-705.77
EPS:
-0.0676
Net Cash Flow:
$1.03B
1W Performance:
+1.86%
1M Performance:
-1.91%
6M Performance:
+17.77%
1Y Performance:
-28.64%
Dupont De Nemours Inc Stock (DD) Company Profile
Name
Dupont De Nemours Inc
Sector
Industry
Phone
(302) 295-5783
Address
974 CENTRE ROAD, WILMINGTON, DE
Compare DD vs LIN, SHW, ECL, APD, PPG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
DD
Dupont De Nemours Inc
|
47.71 | 19.33B | 9.70B | 588.00M | 1.03B | -0.0676 |
|
LIN
Linde plc Ordinary Share
|
512.15 | 236.79B | 34.66B | 7.25B | 5.10B | 15.07 |
|
SHW
Sherwin Williams Co
|
320.79 | 79.12B | 23.94B | 2.60B | 2.91B | 10.42 |
|
ECL
Ecolab Inc
|
269.12 | 75.74B | 16.45B | 2.12B | 1.87B | 7.3955 |
|
APD
Air Products Chemicals Inc
|
280.21 | 62.40B | 12.46B | 2.16B | -1.25B | 9.454 |
|
PPG
Ppg Industries Inc
|
118.25 | 26.36B | 16.12B | 1.59B | 1.23B | 6.9799 |
Dupont De Nemours Inc Stock (DD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-03-25 | Reiterated | Citigroup | Buy |
| Apr-15-25 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-14-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Feb-13-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-17-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-07-24 | Downgrade | Barclays | Equal Weight → Underweight |
| May-28-24 | Upgrade | Citigroup | Neutral → Buy |
| May-24-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| May-23-24 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| May-17-24 | Upgrade | Jefferies | Hold → Buy |
| Mar-01-24 | Initiated | Wolfe Research | Peer Perform |
| Jan-24-24 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jan-24-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-16-24 | Downgrade | BofA Securities | Buy → Underperform |
| Jul-19-23 | Reiterated | Citigroup | Neutral |
| Jun-14-23 | Initiated | Citigroup | Neutral |
| May-15-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-17-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-12-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Dec-20-22 | Resumed | JP Morgan | Overweight |
| Jun-16-22 | Downgrade | Jefferies | Buy → Hold |
| Feb-09-22 | Reiterated | Barclays | Equal Weight |
| Feb-09-22 | Reiterated | BofA Securities | Buy |
| Feb-09-22 | Reiterated | Citigroup | Buy |
| Feb-09-22 | Reiterated | Deutsche Bank | Buy |
| Feb-09-22 | Reiterated | Mizuho | Buy |
| Nov-03-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Nov-03-21 | Upgrade | Vertical Research | Hold → Buy |
| Oct-13-21 | Initiated | Mizuho | Buy |
| Oct-04-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Jul-06-21 | Resumed | Credit Suisse | Neutral |
| May-26-21 | Resumed | Morgan Stanley | Equal-Weight |
| May-11-21 | Upgrade | Goldman | Neutral → Buy |
| Mar-22-21 | Initiated | Barclays | Equal Weight |
| Feb-11-21 | Upgrade | DZ Bank | Sell → Hold |
| Feb-03-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-28-21 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Jan-27-21 | Downgrade | Susquehanna | Positive → Neutral |
| Jan-21-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-14-21 | Downgrade | DZ Bank | Buy → Sell |
| Jan-14-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-13-21 | Downgrade | HSBC Securities | Buy → Hold |
| Jan-13-21 | Downgrade | Vertical Research | Buy → Hold |
| Aug-03-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jun-25-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jun-19-20 | Reiterated | Wells Fargo | Overweight |
| Apr-29-20 | Resumed | Wells Fargo | Overweight |
| Apr-20-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-26-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jan-14-20 | Initiated | Gordon Haskett | Buy |
| Jan-06-20 | Initiated | JP Morgan | Neutral |
| Dec-17-19 | Reiterated | Cowen | Outperform |
| Nov-15-19 | Reiterated | Cowen | Outperform |
| Sep-10-19 | Initiated | Jefferies | Buy |
| Aug-30-19 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Aug-20-19 | Reiterated | Cowen | Outperform |
| Jun-25-19 | Resumed | Monness Crespi & Hardt | Neutral |
| Jun-10-19 | Initiated | Cowen | Outperform |
View All
Dupont De Nemours Inc Stock (DD) Latest News
Qnity Electronics Stock Trends After Hours: CEO Tells Jim Cramer Company 'Right At The Center' Of Materia - Benzinga
Why DuPont’s Kapton MT+ quietly powers the hottest electronics - AD HOC NEWS
DuPont Stockanalyst consensus and technical picture on a quiet news day - AD HOC NEWS
[Latest] Polymeric Biomaterials Market Size Expected to Reach USD 267.25 Billion by 2034, With 15.86% CAGR; Increasing Focus on Regenerative Medicine to Propel Market Growth - GlobeNewswire Inc.
Why DuPont’s SafeGUIDE service wants to rethink everyday plant safety - AD HOC NEWS
DuPont de Nemours, Inc. (NYSE:DD) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Dupont De Nemours Inc (DD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Dupont De Nemours Inc (DD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Dupont De Nemours Inc (DD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Dupont De Nemours Inc (DD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Dupont De Nemours Inc (DD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Dupont De Nemours Inc (DD) Institutional Confidence - TradingKey
Dupont De Nemours Inc (DD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Dupont De Nemours Inc (DD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Dupont De Nemours Inc (DD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
DuPont de Nemours Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
DuPont de Nemours Inc Stock (US26614N1028): Quarterly earnings and portfolio shift in focus - AD HOC NEWS
DuPont de Nemours Inc Stock (US2632451003): Analyst stance and valuation in focus - AD HOC NEWS
DuPont to Unveil New Tyvek® Innovation at Safe@Work 2026 in Thailand - The Manila Times
DuPont Announces Regular Quarterly Dividend on Common Stock - GuruFocus
DuPont de Nemours Stock (US26614N1028): Goldman Sachs starts coverage at Neutral with $53 target - AD HOC NEWS
DuPont de Nemours (NYSE:DD) Coverage Initiated by Analysts at The Goldman Sachs Group - MarketBeat
Goldman Sachs initiates DuPont stock coverage at Neutral on growth - Investing.com
DuPont de Nemours Stock (US26614N1028): valuation focus after recent portfolio moves - AD HOC NEWS
DuPont de Nemours Stock (US26614N1028): Valuation Back In Focus After Recent Share Price Gains - AD HOC NEWS
DuPont MemCor MBR selected for Riverstone upgrade in Australia - MSN
3M, DuPont Seek To Ax Out-Of-State PFAS Claims In Montana - Law360
DuPont de Nemours Inc. stock outperforms competitors on strong trading day - MarketWatch
DuPont Achieves Renewable Power Milestone in US Healthcare Sites - The Globe and Mail
DuPont de Nemours, Inc. Shs Cert Deposito Arg Repr 1/5 Sh Cash Flow – BCBA:DD.CI - TradingView
DuPont de Nemours, Inc. Shs Cert Deposito Arg Repr 1/5 Sh Revenue Breakdown – BCBA:DD.CI - TradingView
DuPont de Nemours Stock (US26614N1028): Shares Jump As Valuation Debate Heats Up - AD HOC NEWS
STALEY CAPITAL ADVISERS INC's DuPont de Nemours Inc(DD) Holding History - GuruFocus
DuPont de Nemours Inc (DD) Shares Surge 4.0% -- What GF Score of 73 Tells Investors - GuruFocus
DuPont Launches FilmTec Hypershell for Energy-Efficient Dairy Processing - MSN
DuPont de Nemours Inc (DD) Stock Down 4.2% but Still Overvalued -- GF Score: 68/100 - GuruFocus
Is DuPont de Nemours stock outperforming the Nasdaq? - MSN
DuPont Announces Healthcare Solutions U.S.-based Manufacturing S - GuruFocus
DuPont Achieves 100% Renewable Energy for Healthcare Manufacturi - GuruFocus
DuPont de Nemours Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DuPont healthcare sites switch to renewable electricity By Investing.com - Investing.com Canada
DuPont Announces Healthcare Solutions U.S.-based Manufacturing Sites Now Powered by 100% Renewable Electricity - Stock Titan
Is DuPont de Nemours Stock Outperforming the Nasdaq? - Barchart.com
Arclin completes acquisition of the DuPont Aramids business, including Iconic Kevlar and Nomex brands - ZAWYA
DuPont™ MemCor™ MBR system selected for major Riverstone Water R - GuruFocus
DuPont (DD) to Enhance Wastewater Treatment in Sydney with New M - GuruFocus
DuPont to supply water treatment system for Sydney facility By Investing.com - Investing.com Canada
Sydney sewage upgrade to treat 24.8M liters a day, protect rivers - Stock Titan
DuPont de Nemours Inc stock (US26614N1028): investors react to latest outlook and portfolio moves - AD HOC NEWS
DuPont de Nemours Inc. stock underperforms Friday when compared to competitors - MarketWatch
DuPont plummets over 100 spots on Fortune 500 list of largest companies - The News Journal
Dupont De Nemours Inc Stock (DD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):